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Objective: To undertake a survey of nasopharyngeal carriage of Streptococcus pneumoniae, which reflects strains 
causing infection, in 100 children under 3 years of age attending day-care centers in  Frosinone, a city near Rome. 
Methods: Fifty-three unique isolates of S. pneumoniae, isolated from 41 of the children tested, were tested for 
antimicrobial susceptibility to penicillin, cefotaxime, erythromycin, clindamycin, tetracycline, chloramphenicol and 
trimethoprim-sulfamethoxazole. 
Results: Resistance rates were as follows: penicillin, 20.7% (15% intermediate; 5.7% resistant); trimethoprim- 
sulfamethoxazole, 64.2%; erythromycin, 64.2%; clindamycin, 30.2%; tetracycline, 32.1%; and chloramphenicol, 3.8%. 
Except for three intermediate strains, all strains were susceptible to cefotaxime. Only five strains were susceptible to  all 
of the antibiotics tested. An unusual finding of this study was that 23 of the 34 erythromycin-resistant strains were 
penicillin susceptible, whereas erythromycin-resistant strains found in other countries are predominantly penicillin 
resistant as well. In addition, 18 of the 34 erythromycin-resistant strains were susceptible to clindamycin. Serogroups 6, 
14, 19 and 23 accounted for 84.9% of the isolates. 
Conclusions: These data show that carriage of antibiotic-resistant pneumococci in children under 3 years of age is 
high in Frosinone, Italy. Information on resistance rates in pneumococcal disease in  different age groups and on 
prevalence of drug resistance in other parts of the country is urgently needed. 
I NTRO DUCT1 0 N 
Strrpforocrits prieitmorriur is a major cause of mortality 
and morbidity worldwide. It  is the most common 
cause of community-acquired bacterial respiratory tract 
infections and bacterial meningitis in adults and the 
Corresponding author and reprint requests: 
Michael R. Jacobs, Department of Pathology, 
University Hospitals of Cleveland, 11100 Euclid Avenue, 
Cleveland, OH 44106, USA 
Tel: +I 216 844 3484 Fax: + I  216 844 5601 
E-mail: mrj6@po.cwru.edu 
Accepted 7 May 1998 
leading cause of death in children under 2 years of age 
in developing countries, causing about 1.2 million 
deaths annually in this age group [1,2]. Children below 
2 years of age, the elderly, and patients with inipaired 
defense mechanisms as a result of, for example, HIV 
infection, diabetes inellitus, malnutrition, sickle cell 
anemia, splenectomy, agamniaglobuliiiemia, multiple 
myeloma, chronic lymphocytic leukemia, hepatic 
cirrhosis, chronic pulmonary disease and prior viral 
infection, have the highest infection rates. S. pneirrnoninr 
is the coninlonest cause of acute otitiv media cvorld- 
wide, being responsible for 30-50%1 of episodes [3,4], 
A S  well as the leading cause of bactereniia and bacterial 
nieningitis [5,6]. At highest risk for pneuinococcal 
disease are children in the first 2. years of life and the 
elderly [7].  
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While S. pneumoniae was initially fully susceptible 
to penicillin (MICs 50.03 mg/mL), decreased suscepti- 
bility was first documented in Boston in 1965 [8]. 
Subsequently, this phenomenon was reported from 
Australia in 1967 [9] and South Africa in 1977 [lo]. 
Since these early reports, antibiotic-resistant pneumo- 
cocci have been reported around the world. However, 
information on antibiotic susceptibility patterns in 
many countries is not available. While nasopharyngeal 
carriage of S. pneumoniae without disease occurs in all 
age groups, carriage rates differ with age, being highest 
in children [4]. More than 95% of children have had an 
episode of nasopharyngeal pneumococcal colonization 
by 2 years of age [l], while 30-60% are nasopharyngeal 
carriers of pneumococci at any point in time. A given 
serotype is carried from a month to a year, with an 
average of 6 weeks [ l l ] .  As pneumococcal disease 
follows nasopharyngeal carriage [12], it is not surprising 
that studies done in South Africa and Pakistan showed 
that the antimicrobial susceptibility profile of naso- 
pharyngeal strains reflects that of invasive strains in the 
same age group [13-151. Therefore, surveillance of 
pneumococcal resistance in nasopharyngeal isolates is a 
practical way to determine the prevalence of resistant 
strains in children and is considered a reasonable 
predictor of resistance in disease. 
Mediterranean countries such as Spain and France 
are currently known to have high prevalence rates of 
penicillin-resistant pneumococci, but information on 
the prevalence of penicillin-resistant pneumococci, the 
patterns of antibiotic resistance and the serogroups/ 
serotypes of resistant strains is lacking in Italy. The best 
data from Italy have been published by Marchese et al: 
they tested about 300 strains from the north of Italy 
and found the percentage of penicillin-non-susceptible 
pneumococci to be 5.5%, including equal numbers 
of penicillin-intermediate and -resistant strains [16]. 
In 1996, as part of the Alexander Project, data were 
presented which confirmed the very low rate of peni- 
cillin-resistant pneumococci in northern Italy, with 8% 
of strains being penicillin intermediate [17]. 
Nasopharyngeal secretions were collected pernasally 
with calcium alginate swabs on flexible aluminum shafts. 
Swabs were placed in 0.85% saline and transported after 
a maximum of 3 h from collection to the Pediatric 
Microbiology Laboratory of Policlinico Umberto I in 
Rome. Specimens were plated onto Columbia agar 
plates supplemented with 5% sheep blood agar with 
and without 5 mg of gentamicin per liter (Becton 
Diclunson, Milan, Italy). An optochin disk was placed 
on each plate and the plates were incubated overnight 
at 35°C in a 5% C 0 2  atmosphere. Isolates of S. pneu- 
moniae were identified by a zone of inhibition around 
the optochin disk and by a positive bile solubility test. 
Strains were subcultured and overnight growth was 
suspended in serum glycerol freezing medium and 
stored at -70°C. Strains were transported by air to 
Case Western Reserve University in accordance with 
local and international shipment regulations. The 
identification of strains was confirmed in Cleveland by 
positive bile solubility tests, and susceptibility testing 
was performed on Mueller-Hinton agar supplemented 
with 5% sheep blood agar (Becton Dickson Micro- 
biology Systems, Cockeysville, MD) . Susceptibility to 
the following agents was determined by disk diffusion: 
chloramphenicol (30-pg disks), tetracycline (30-pg 
disks), erythromycin (15-pg disks), clindamycin (2-pg 
disks), and trimethoprim-sulfamethoxazole (25-pg 
disks). Plates were incubated overnight in 5% CO2 and 
zones of inhibition read and interpreted according to 
National Committee for Clinical Laboratory Standards 
criteria [18]. All isolates were also screened for penicillin 
resistance using disks containing 1 pg of oxacillin. 
MICs to penicillin and cefotaxime were determined by 
the E-test method (AB Biodisk, Solna, Sweden) on 
strains with oxacillin zones of <20 mm [18,19]. Strains 
resistant to three or more classes of antimicrobial agents 
were considered multiply resistant. 
Strains were serogrouped by the capsular swelling 
method using commercially available antisera (Statens- 
serum Institute, Copenhagen, Denmark). 
RESULTS 
MATERIALS AND METHODS 
Children aged 8-36 months attending three different 
day-care centers were included in this study The day- 
care centers were in Frosinone, a city 80 km from 
Rome, with a population of 100 000. Nasopharyngeal 
carriage of S. pneurnoniae was determined on three 
different occasions at the day-care centers: December 
1995, March 1996 and April 1996. The local public- 
health authorities gave the ethical approval of the study 
and an informed written consent was obtained from the 
parents of the children. 
One hundred children attending the three day-care 
centers were enrolled in the study. The mean age of the 
children was 25 months (range 8-36 months), and 
51% were male. There were no significant differences 
between age and sex distributions among the three 
centers. During the investigation period, 52 children 
were tested three times, 26 children twice, and 22 
children once, with a total of 230 swabs being obtained. 
Strains with the same susceptibility pattern and sero- 
group from the same carrier were only included once 
in data analysis. 
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Overall, 41%) of the 100 children carried 53 strains 
of S. pneumoniae on one or more occasions. Thirty 
children were only tested once (N=22) or carried the 
same strain on retesting. Ten children carried a different 
strain on retesting, and one child carried three different 
strains on the three occasions. The carriage rate was 
65.2% in center 2 (N=23), 39.6% in center 1 (N=48), 
and 24.1% in center 3 (N=29). 
Susceptibility testing of the 53 strains from 41 
children showed that only five strains were susceptible 
to all agents tested, while 48 strains were resistant to 
one or more agents (Tables 1 and 2). Eleven strains 
(20.7%) had decreased susceptibility to penicillin, with 
eight being intermediate (MICs ranging from 0.12 to 
0.5 mg/L) and three resistant (MICs 2 mg/L); nine of 
these strains were multiply resistant. The three peni- 
cillin-resistant strains were all resistant to tetracycline, 
erythromycin, clindamycin and trimethoprim-sulfa- 
Table 1 Susceptibility of S. pnarrrnoniae to agents tested 
No. (percentage) of strains 
Susceptible Interinediate Ilesistaiit 
I’enicillin 42 (79.2) 8 (15.8) 3 (5.7) 
Cefotaxime SO (94.3) 3 (5.7) ~ 
Erythromycin 19 (35.8) - 34 (64.2) 
~ ~ l ~ l d d ~ l ~ C l 1 1  37 (69.8) ~ 16 (30.3) 
rulfamcthoxazolc 19 (35.8) ~ 34 (64.2) 
Tetracycline 36 (67.9) ~ 17 (32.1) 
Chloraiiiphcnicol 51 (96.2) - 2 (3.8) 
Trimethoprini- 
Table 2 Resistance patterns and cerotypes of S. pncnmoniac 
isolates 
No. of strains of serogroup 
Ke\i\tance 
pattern 6 14 10 13  33 Other Total 
25 4 9 7 5 3 53 
€? penicillin: E, erythroiiiycin; C’, chndarnycin; S, trimechoprim- 
~ulfamethoxazolr; T, tetracycline; C. chlorainphenicol. 
,‘Penicillin intermediate; hpenicilhn resistant; ‘one penicillin 
interinediate and one penicillin resistant. 
rnethoxazole, and one strain was also resistant to 
chloramphenicol (Table 2). The three penicillin- 
resistant strains had intermediate susceptibhty to 
cefotaxime (MICs 1 mg/L), with all other strains 
being susceptible to this agent. Erythromycin and 
trimethoprim-sulfamethoxazole resistance was found 
in 34 strains (64.2%), while 16 strains (30.2%) were 
resistant to clindamycin. Seventeen strains (32.1%) were 
resistant to tetracycline, and two strains (3.8%) to 
chloramphenicol. 
Of  the 53 strains isolated, 25 (47.2%) belonged to 
serogroup 6, nine (17%) to serogroup 19, seven (13.2%) 
to serogroup 23, five (9.4%) to serogroup 33, four to 
serotype 14, and three to other serogroups. Correlations 
between susceptibility patterns and serogroups are 
shown in Table 2. The commonest pattern was 
serogroup 6, resistant to erythromycin and 
trimethoprim-sulfamethoxazole. with 15 strains (1 1 
from center 2, three from center 1 and one from center 
3). Six serogroup 6 strains resistant only to 
trimethoprim-sulfaniethoxazole were recovered from 
carriers in center 1. Only five strains were susceptible 
to all agents tested, and all belonged to serogroup 33: 
these strains were found in centers 1 and 3. Different 
patterns were found in the three day-care centers, 
with erythromycin and trimethoprim-sulfaniethoxa- 
zole-resistant serogroup 6 strains predominating in 
center 2 and trimethoprini-sulfamethoxazole-resistant 
serogroups 6 and 23 in center 1 .  
DISCUSSION 
The rising prevalence of antibiotic-resistant pneumo- 
cocci worldwide mandates selective susceptibility 
testing, epidemiologic surveillance, rational use of 
antimicrobial agents, and re-evaluation of indications 
for therapeutic and prophylactic use of antimicrobial 
agents. 
The clinical implications of infections with drug- 
resistant pneumococci have not been fully established. 
Retrospective studies have shown that penicillin is 
inadequate for treatment of meningitis due to peni- 
cillin-resistant pneumococci [I 9-22]. The impact of in 
vitro drug resistance on the clinical outcome of nori- 
meningeal pneuniococcal infections such as bacteremia, 
pneumonia, otitis media and sinusitis is yet to be 
clarified [1,19,20]. As the degree of resistance of 
pneuniococci to p-lactanis is variable, the level of drug 
achievable at  sites of infection may greatly influence 
the outcome of infections, especially with orally 
administered agents 12 11. Consequently, the usefulness 
of a p-lactani agent in treating pneuniococcal infections 
depends on the site and nature of the infection, the 
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route of drug administration, the bioavailability of the 
drug, and the MIC of the agent against the organism. 
This is a particular problem in otitis media, where the 
penetration of orally administered antibiotics into 
middle ear fluid is poor and levels are often below 
MICs of penicillin-resistant pneumococci. As a result 
of decreased activity of many oral 0-lactams against 
penicillin-resistant strains, such strains have been 
recognized as causes of treatment failure in acute otitis 
media and mastoiditis and as causes of chronic sinusitis 
and otitis media [22-251. O f  the oral 0-lactams, 
amoxycillin has the best pharmacodynamic parameters 
and good bioavailability in the middle ear, and this 
agent remains the recommended initial empirical agent 
for treatment of otitis media even in areas of high 
prevalence of penicillin-intermediate and -resistant 
pneumococci [20,21]. Myringotomy or tympano- 
centesis should be done to permit identification of 
causative organisms and tests of susceptibility to anti- 
biotics in patients who do not respond to antibiotic 
therapy. Agents to which the organisms are susceptible 
can then be used. 
This study showed that the majority of pneumo- 
cocci carried by children attending three day-care 
centers in a central Italian city were resistant to one 
or more classes of agents, with 66.7% being multiply 
resistant. Of  particular concern is the finding of 
34 strains (64.2%) resistant to erythromycin (and 
therefore other macrolides) and to trimethoprim- 
sulfamethoxazole, 17 strains (32.1%) resistant to 
clindamycin, and 11 strains (20.8%) intermediate or 
resistant to penicillin. An important and unusual 
finding of this study was that 23 of the 34 
erythromycin-resistant strains were penicihn susceptible, 
whereas erythromycin-resistant strains found in other 
countries are predominantly penicillin resistant as well. 
In addition, 18 of the 34 erythromycin-resistant strains 
were susceptible to clindamycin, a feature frequently 
seen in US strains due to the presence of a macrolide- 
efflux pump 1261. In a recent study from Greece, all 
erythromycin-resistant strains were resistant to clinda- 
niycin [27], as was also reported in erythromycin- 
resistant S. pyogener in Italy 128). 
0-Lactam resistance in pneumococci, due to 
multiple PBP changes, can often be overcome if 
adequate drug levels can be attained at the site of 
infection. Resistance to macrolides and trimethoprim- 
sulfamethoxazole is absolute and not able to be 
overcome by pharmacologically achievable levels of 
these agents [20]. The findings of this study therefore 
suggest that macrolides and trimethoprim-sulfa- 
methoxazole are unsuitable for empirical use in the 
communities where these children live. As most of the 
penicillin-non-susceptible strains were in fact penicillin 
intermediate, use of the more active oral 0-lactams such 
as amoxycillin and cefuroxime axetil, which are active 
against penicillin-intermediate strains, should be con- 
sidered for empirical use in otitis media, sinusitis and 
bronchitis [20-251. 
As found throughout the world [l-51, serogroups 
6, 14, 19 and 23 accounted for the majority (84.9%) 
of isolates. They are the commonest serogroups in 
children and the types most often associated with 
resistance. Although the 23-valent vaccine contains 
serotypes representative of these serogroups, it is 
ineffective in children below 2 years 1121, and develop- 
ment of conjugate vaccines that are immunogenic in 
this age group is an important goal to reduce carriage 
of these serotypes and thus the spread of these strains as 
well as infections with these strains. 
It is difficult to compare data from the present 
study with the few published data on antibiotic 
susceptibility of S. pneumoniae in Italy, because the 
published data were obtained from the north of Italy 
from a predominantly adult population. This may 
explain why in a different part of the country 
(central-south) the present study found a substantially 
higher prevalence of penicillin-intermediate and 
-resistant pneumococci in children < 36 months old. 
However, the data from Marchese et a1 [I61 showed that 
penicillin-resistant pneumococci were often multiply 
resistant, as was found in the present study. In contrast 
to two Italian studies, where erythromycin resistance 
rates were 3-4% [16,17], the rate of erythromycin 
resistance was considerably higher (64%) in the present 
study. In addition, erythromycin resistance was found 
in both penicillin-susceptible (61.9%) and -resistant 
(72.7%) strains, whereas macrolide resistance was pre- 
dominantly found in penicillin-resistant strains in these 
published studies. 
In conclusion, this study has shown that consider- 
able antimicrobial resistance is present in S. pneumoniae 
strains carried by children attending day-care centers in 
south-central Italy. Further surveillance is necessary to 
extend these findings to other parts of the country. 
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